THE DEAL, AT A GLANCE
From the announcementQL Biopharm
01Who is involvedBacked by Cathay CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedQL Biopharm raised $45M Series C, announced 2026-09-14From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersQL Biopharm's Series C extension suggests continued investor support for a biopharma company that still requires private capital to advance its next stage of development.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
QL Biopharm · Financing Record
Explore source-linked visual explanations for QL Biopharm. Unsupported claims are withheld while source review continues.
Record 12262 · Recorded date: 2026-09-14
Explore company records →